ETFs DexCom, Inc.

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 04/09/2026 am IST			5-day change	1st Jan Change
89.71 ^USD	+0.02%		+0.47%	+35.17%

25/08	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT

ETFs positioned on DexCom, Inc.

Name	YTD change	Weight	AuM
INVESCO QQQ ETF - USD	+16.83%	-.--%	334,922 M€
AMPLIFY AI POWERED EQUITY ETF - USD	+12.81%	-.--%	124 M€
PACER MSCI WORLD INDUSTRY ADVANTAGE ETF - USD	0.00%	-.--%	1 M€
PACER PE/VC ETF - USD	+14.42%	-.--%	3 M€
JPMORGAN ETFS (IRELAND) ICAV - GLOBAL RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF (DIST) - USD	+11.69%	-.--%	44 M€
VANGUARD FTSE ALL-WORLD UCITS ETF - USD	+13.67%	-.--%	27,154 M€
CI GROWTH ASSET ALLOCATION ETF -CAD	+10.61%	-.--%	67 M€
AMUNDI MSCI WORLD CATHOLIC PRINCIPLES UCITS ETF ACC - USD	+14.40%	-.--%	112 M€
MOTLEY FOOL MID-CAP GROWTH ETF - USD	-2.39%	-.--%	119 M€
FUNDX CONSERVATIVE ETF - USD	+6.72%	-.--%	49 M€
SOUNDWATCH HEDGED EQUITY ETF - USD	+4.46%	-.--%	165 M€
STATE STREET SPDR S&P 500 UCITS ETF - USD	+13.72%	-.--%	21,745 M€
STATE STREET SPDR S&P WORLD EX AUSTRALIA CARBON AWARE (HEDGED) ETF - AUD	+3.51%	-.--%	293 M€
FIRST TRUST NASDAQ LUX DIGITAL HEALTH SOLUTIONS ETF - USD	+16.61%	8.13%	4 M€
CI GLOBAL LONGEVITY ECONOMY FUND ETF - CAD	-.--%	7.1%	3 M€
VANECK GENOMICS AND HEALTHCARE INNOVATORS UCITS ETF - USD	+23.22%	6.36%	15 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH ETF - USD	+1.42%	6.09%	31 M€
VANECK BIONIC ENGINEERING UCITS ETF - USD	-7.11%	5.89%	13 M€
GLOBAL X INTERNET OF THINGS ETF - USD	+27.59%	5.15%	224 M€
GLOBAL X INTERNET OF THINGS UCITS ETF - USD	+27.48%	4.63%	3 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH UCITS ETF DIST - USD	+12.14%	4.09%	0 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH UCITS ETF - USD	+12.74%	3.7%	6 M€
ISHARES U.S. MEDICAL DEVICES ETF - USD	-13.26%	3.39%	3,478 M€
GOLDMAN SACHS FUTURE HEALTH CARE EQUITY ETF - USD	+6.18%	2.68%	20 M€
MOTLEY FOOL GLOBAL OPPORTUNITIES ETF - USD	+4.06%	2.4%	362 M€
CI ALTERNATIVE NORTH AMERICAN OPPORTUNITIES FUND - CAD	+7.43%	2.29%	36 M€
CI ALTERNATIVE NORTH AMERICAN OPPORTUNITIES FUND - USD	+13.37%	2.29%	6 M€
FIRST TRUST NASDAQ-100 SELECT EQUAL WEIGHT ETF - USD	+14.33%	2.19%	1,856 M€
ISHARES US MEDICAL DEVICES UCITS ETF (ACC) - USD	-15.54%	2.09%	234 M€

1 2 3 4 5

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.

Employees

11,050

Sector

Medical Equipment, Supplies & Distribution

More about the company